ONCOLYTICS BIOTECH INC (ONCY)

CA6823108759 - Common Stock

0.831  -0.06 (-6.36%)

After market: 0.8297 0 (-0.16%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
N/AN/AN/AN/A
846.83%		N/A
550.60%		N/A
249.36%		N/A
77.25%		N/A
-9.19%		N/A
38.33%
EBITDA
YoY % growth
-23.69M-18.43M
22.20%		-14.32M
22.30%		-14.96M
-4.47%		-15.59M
-4.21%		-17.17M
-10.13%		-19.88M
-15.78%		-25.01M
-25.80%		-25.78M
-3.08%		-26.53M
-2.91%		N/A
-36.12%		N/A
-10.05%		N/A
-46.70%		N/A
17.26%		N/A
36.26%		N/A
385.88%		N/A
137.54%		N/A
-14.97%		N/A
44.36%
EBIT
YoY % growth
-23.82M-18.59M
21.96%		-14.5M
22.00%		-15.12M
-4.28%		-15.68M
-3.70%		-17.27M
-10.14%		-20.37M
-17.95%		-25.46M
-24.99%		-26.23M
-3.02%		-26.92M
-2.63%		N/A
-33.84%		N/A
-4.55%		N/A
-30.75%		N/A
49.91%		N/A
48.75%		N/A
756.84%		N/A
127.18%		N/A
11.29%		N/A
47.10%
Operating Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
-2.66-1.90
28.57%		-1.14
40.00%		N/A
-13.62%		-1.14
11.99%		-1.04
9.21%		-0.93
10.14%		-0.43
53.76%		-0.49
-13.95%		-0.44
10.20%		-0.41
6.82%		N/A
-5.34%		N/A
-12.09%		N/A
19.51%		N/A
45.23%		N/A
723.43%		N/A
106.40%		N/A
46.36%		N/A
30.98%

All data in CAD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.12
-142.14%		-0.12
-34.67%		-0.11
-11.10%		-0.11
7.42%		-0.11
12.41%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-12.219M
-44.68%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-10.839M
-22.49%		N/AN/AN/AN/A

All data in CAD

Recent Earnings VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.12
14.29%		-0.10-0.02-15.35%
Q2 2024
Q2Q % growth		 -0.10
16.67%		-0.100.003.10%
Q1 2024
Q2Q % growth		 -0.09
10.00%		-0.110.0217.49%
Q4 2023
Q2Q % growth		 -0.05
66.67%		-0.150.1066.41%
Q3 2023
Q2Q % growth		 -0.14
-75.00%		-0.11-0.03-33.28%
Q2 2023
Q2Q % growth		 -0.12
-33.33%		-0.11-0.01-5.24%
Q1 2023
Q2Q % growth		 -0.10
16.67%		-0.130.0325.28%
Q4 2022
Q2Q % growth		 -0.15
-7.14%		-0.10-0.05-53.17%
Q3 2022
Q2Q % growth		 -0.08
11.11%		-0.110.0327.82%
Q2 2022
Q2Q % growth		 -0.09
30.77%		-0.110.0216.46%
Q1 2022
Q2Q % growth		 -0.12
7.69%		-0.150.0318.99%
Q4 2021
Q2Q % growth		 -0.14
36.36%		-0.13-0.01-9.43%
Q3 2021
Q2Q % growth		 -0.09
43.75%		-0.140.0537.83%
Q2 2021
Q2Q % growth		 -0.13
23.53%		-0.12-0.01-7.26%
Q1 2021
Q2Q % growth		 -0.13
-208.33%		-0.180.0525.74%
Q4 2020
Q2Q % growth		 -0.22
12.00%		-0.15-0.07-45.21%
Q3 2020
Q2Q % growth		 -0.16
-6.67%		-0.14-0.02-13.15%
Q2 2020
Q2Q % growth		 -0.17
34.62%		-0.14-0.03-24.68%
Q1 2020
Q2Q % growth		 0.12
144.44%		-0.250.37147.52%
Q4 2019
Q2Q % growth		 -0.25
10.71%		-0.15-0.10-65.02%
Q3 2019
Q2Q % growth		 -0.15
25.00%		-0.220.0732.49%
Q2 2019
Q2Q % growth		 -0.26
3.70%		-0.260.00-0.95%
Q1 2019
Q2Q % growth		 -0.27
5.26%		-0.290.027.82%
Q4 2018
Q2Q % growth		 -0.28 -0.26-0.02-6.63%
Q3 2018
Q2Q % growth		 -0.20 -0.280.0827.99%
Q2 2018
Q2Q % growth		 -0.27 0.05-0.32-634.65%
Q1 2018
Q2Q % growth		 -0.29 -0.19-0.09-48.51%
Recent Revenue VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Q4 2018
Q2Q % growth		 505K-505K-100.00%
Q2 2018
Q2Q % growth		 6.06M-6.06M-100.00%
Q1 2018
Q2Q % growth		 2.02M-2.02M-100.00%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -20.52% 0% 0%
RevenueN/A -100% N/A N/A